Saakshi Medtech

Why is Saakshi Medtech & Panels Ltd falling/rising?

As of 02-Sep, Saakshi Medtech & Panels Ltd's stock price is rising to 310.90, reflecting a 0.61% increase. This upward trend is supported by strong performance against the Sensex, increased investor participation, and trading above key moving averages.

As of 02-Sep, Saakshi Medtech & Panels Ltd's stock price is rising, currently at 310.90, with a change of 1.9 (0.61%) upward. This positive movement can be attributed to several factors. Over the past week, the stock has outperformed the benchmark Sensex, gaining 9.39% compared to the Sensex's decline of 1.21%. Similarly, in the past month, the stock has increased by 5.19%, while the Sensex has fallen by 1.92%. <BR><BR>Additionally, the stock is trading above its moving averages across various time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a strong upward trend. There has also been a notable increase in investor participation, with a delivery volume of 30.6k on September 1, which is 30.77% higher than the 5-day average. This suggests growing interest and confidence among investors in the stock. Furthermore, the stock's liquidity is sufficient for trading, as it meets the criteria based on the average traded value. <BR><BR>Overall, these factors contribute to the rising price of Saakshi Medtech & Panels Ltd.

Which are the latest news on Saakshi Medtech?

What does Saakshi Medtech do?

Saakshi Medtech & Panels Ltd is a Micro Cap company in the Other Electrical Equipment industry, originally incorporated in 2009. It has no recent sales or profit data, with a market cap of INR 523 Cr and a P/E ratio of 42.00.

Overview:<BR>Saakshi Medtech & Panels Ltd operates in the Other Electrical Equipment industry and is classified as a Micro Cap company.<BR><BR>History:<BR>The company was originally incorporated as a Private Limited Company under the name "Saakshi Machine and Tools Private Limited" on March 25, 2009. It later took over the business of a proprietorship concern on January 27, 2012. There is no recent sales or profit data reported.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: N/A<BR>Most recent Net Profit: N/A<BR>Market-cap value: INR 523 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 42.00<BR>Industry P/E: 69<BR>Dividend Yield: 0.00%<BR>Debt Equity: 0.21<BR>Return on Equity: 11.14%<BR>Price to Book: 4.74<BR><BR>Contact Details:<BR>Address: Not available<BR>Phone: N/A<BR>Email: N/A<BR>Website: N/A

Who are the peers of the Saakshi Medtech?

Saakshi Medtech's peers include Supreme Power, Australian Prem, Focus Lighting, Artemis Electri, Delton Cables, and Sugs Lloyd. Saakshi Medtech has below average management risk and good growth, with a 1-year return of 67.75%, outperforming Australian Prem and underperforming Supreme Power.

Peers: The peers of Saakshi Medtech are Supreme Power, Australian Prem, Focus Lighting, Artemis Electri., Delton Cables, and Sugs Lloyd.<BR><BR>Quality Snapshot: Excellent management risk is observed at Supreme Power and Sugs Lloyd, while Average management risk is found at Australian Prem and Delton Cables, and Below Average management risk is noted at Saakshi Medtech and Artemis Electri. Growth is Excellent at Supreme Power and Australian Prem, Good at Saakshi Medtech, and Below Average at Focus Lighting and Artemis Electri. Capital Structure is Excellent at Australian Prem, Good at Supreme Power, Saakshi Medtech, and Artemis Electri., while Average is noted at Sugs Lloyd and Below Average at Delton Cables.<BR><BR>Return Snapshot: Saakshi Medtech's 1-year return is 67.75%, which is higher than Australian Prem's lowest return of -47.34% and lower than Supreme Power's highest return of 13.39%. Additionally, Focus Lighting and Australian Prem have negative six-month returns.

How big is Saakshi Medtech?

As of 10th June, Saakshi Medtech & Panels Ltd has a market capitalization of 450.00 Cr, classifying it as a Micro Cap company. There is no valid financial data available for the latest four quarters, but as of March 2025, Shareholder's Funds are 98.04 Cr and Total Assets are 131.10 Cr.

As of 10th June, <BR><BR>Market Cap: Saakshi Medtech & Panels Ltd has a market capitalization of 450.00 Cr, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: There is no valid financial data available for the latest four quarters, including Net Sales and Net Profit.<BR><BR>Balance Sheet Snapshot: The latest reporting period is March 2025, with Shareholder's Funds amounting to 98.04 Cr and Total Assets valued at 131.10 Cr.

How has been the historical performance of Saakshi Medtech?

Saakshi Medtech has experienced a decline in key financial metrics, with net sales and operating profit decreasing from Mar'23 to Mar'25, while total assets and liabilities increased. Cash flow from operations also fell significantly, indicating reduced profitability despite asset growth.

Answer:<BR>The historical performance of Saakshi Medtech shows significant fluctuations in key financial metrics over the years.<BR><BR>Breakdown:<BR>Saakshi Medtech's net sales have decreased from 122.06 Cr in Mar'23 to 92.43 Cr in Mar'25, reflecting a downward trend. The total operating income followed a similar pattern, dropping from 122.06 Cr in Mar'23 to 92.43 Cr in Mar'25. The raw material costs also decreased from 73.93 Cr in Mar'23 to 58.81 Cr in Mar'25, indicating a reduction in production costs. Operating profit (PBDIT) saw a decline from 20.70 Cr in Mar'23 to 10.88 Cr in Mar'25, with the operating profit margin decreasing from 16.84% to 11.15%. Profit before tax fell from 16.59 Cr in Mar'23 to 6.59 Cr in Mar'25, leading to a profit after tax of 4.71 Cr in Mar'25, down from 12.38 Cr in Mar'23. The company's total assets increased from 93.24 Cr in Mar'23 to 131.10 Cr in Mar'25, while total liabilities also rose from 93.24 Cr to 131.10 Cr in the same period. Cash flow from operating activities decreased from 10.00 Cr in Mar'23 to 3.00 Cr in Mar'25, contributing to a net cash outflow of 12.00 Cr in Mar'25. Overall, Saakshi Medtech's financial performance has shown a decline in profitability and cash flow, despite an increase in total assets and liabilities.

Is Saakshi Medtech overvalued or undervalued?

As of November 6, 2025, Saakshi Medtech is considered very expensive and overvalued with a PE ratio of 65.09, an EV to EBITDA ratio of 31.15, and a year-to-date return of -22.64%, significantly underperforming compared to its peers and the Sensex.

As of 6 November 2025, the valuation grade for Saakshi Medtech has moved from expensive to very expensive. The company is currently overvalued, indicated by a PE ratio of 65.09, an EV to EBITDA ratio of 31.15, and a Price to Book Value of 3.13. In comparison to its peers, Adani Enterprises has a PE ratio of 127.79 and an EV to EBITDA of 29.94, while Tata Chemicals shows a PE of 60.22 and an EV to EBITDA of 16.15, suggesting that Saakshi Medtech's valuation is significantly higher than many of its competitors.<BR><BR>The company's recent performance has also been underwhelming, with a year-to-date return of -22.64%, contrasting sharply with the Sensex's gain of 7.89% over the same period. This further reinforces the notion that Saakshi Medtech is not only overvalued but also struggling to deliver returns in the current market environment.

Who are the top shareholders of the Saakshi Medtech?

The top shareholders of Saakshi Medtech include promoter Chitra Vijay Latkar with 66.27%, individual investors with 22.37%, and public shareholder Jatinder Agarwal at 4.84%. There are no pledged promoter holdings or mutual funds invested in the company.

The top shareholders of Saakshi Medtech include the promoters, with Chitra Vijay Latkar holding the largest share at 66.27%. Additionally, individual investors collectively own 22.37% of the company. The highest public shareholder is Jatinder Agarwal, who holds 4.84%. There are also two foreign institutional investors (FIIs) that hold a combined 0.1%. Notably, there are no pledged promoter holdings and no mutual funds currently invested in the company.

What is the technical trend for Saakshi Medtech?

As of June 3, 2025, Saakshi Medtech's trend has shifted to sideways with mixed signals; while the weekly MACD and KST are mildly bullish, daily moving averages and monthly Bollinger Bands indicate a mildly bearish outlook, reflecting overall market indecision.

As of 3 June 2025, the technical trend for Saakshi Medtech has changed from mildly bearish to sideways. The current stance is neutral, with mixed signals across different indicators. The weekly MACD is mildly bullish, while the daily moving averages indicate a mildly bearish trend. The Bollinger Bands show a bullish signal on the weekly chart but are mildly bearish on the monthly chart. The KST and OBV are both mildly bullish on the weekly timeframe, supporting the sideways trend. Overall, the strength of the trend is weak, reflecting indecision in the market.

When is the next results date for Saakshi Medtech?

No Upcoming Board Meetings

Has Saakshi Medtech declared dividend?

No Dividend History Available